| Product Code: ETC10762495 | Publication Date: Apr 2025 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
The import trend of pediatric vaccines in the Bahamas experienced a significant decline from 2020 to 2024, with a Compound Annual Growth Rate (CAGR) of -68.07%. This sharp decrease in imports resulted in a year-on-year growth rate of zero in 2023-2024, reflecting a challenging market situation during this period.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bahamas Pediatric Vaccine Market Overview |
3.1 Bahamas Country Macro Economic Indicators |
3.2 Bahamas Pediatric Vaccine Market Revenues & Volume, 2022 & 2032F |
3.3 Bahamas Pediatric Vaccine Market - Industry Life Cycle |
3.4 Bahamas Pediatric Vaccine Market - Porter's Five Forces |
3.5 Bahamas Pediatric Vaccine Market Revenues & Volume Share, By Vaccine Type, 2022 & 2032F |
3.6 Bahamas Pediatric Vaccine Market Revenues & Volume Share, By Disease Type, 2022 & 2032F |
3.7 Bahamas Pediatric Vaccine Market Revenues & Volume Share, By Technology, 2022 & 2032F |
3.8 Bahamas Pediatric Vaccine Market Revenues & Volume Share, By End User, 2022 & 2032F |
3.9 Bahamas Pediatric Vaccine Market Revenues & Volume Share, By Age Group, 2022 & 2032F |
4 Bahamas Pediatric Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Bahamas Pediatric Vaccine Market Trends |
6 Bahamas Pediatric Vaccine Market, By Types |
6.1 Bahamas Pediatric Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Bahamas Pediatric Vaccine Market Revenues & Volume, By Vaccine Type, 2022 - 2032F |
6.1.3 Bahamas Pediatric Vaccine Market Revenues & Volume, By Live Attenuated, 2022 - 2032F |
6.1.4 Bahamas Pediatric Vaccine Market Revenues & Volume, By Inactivated, 2022 - 2032F |
6.1.5 Bahamas Pediatric Vaccine Market Revenues & Volume, By Subunit, 2022 - 2032F |
6.1.6 Bahamas Pediatric Vaccine Market Revenues & Volume, By Toxoid, 2022 - 2032F |
6.1.7 Bahamas Pediatric Vaccine Market Revenues & Volume, By Conjugate, 2022 - 2032F |
6.2 Bahamas Pediatric Vaccine Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 Bahamas Pediatric Vaccine Market Revenues & Volume, By Respiratory Infections, 2022 - 2032F |
6.2.3 Bahamas Pediatric Vaccine Market Revenues & Volume, By Gastrointestinal Diseases, 2022 - 2032F |
6.2.4 Bahamas Pediatric Vaccine Market Revenues & Volume, By Neurological Diseases, 2022 - 2032F |
6.2.5 Bahamas Pediatric Vaccine Market Revenues & Volume, By Bloodborne Diseases, 2022 - 2032F |
6.2.6 Bahamas Pediatric Vaccine Market Revenues & Volume, By Bacterial Infections, 2022 - 2032F |
6.3 Bahamas Pediatric Vaccine Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Bahamas Pediatric Vaccine Market Revenues & Volume, By mRNA, 2022 - 2032F |
6.3.3 Bahamas Pediatric Vaccine Market Revenues & Volume, By Recombinant, 2022 - 2032F |
6.3.4 Bahamas Pediatric Vaccine Market Revenues & Volume, By DNA-Based, 2022 - 2032F |
6.3.5 Bahamas Pediatric Vaccine Market Revenues & Volume, By Viral Vector, 2022 - 2032F |
6.3.6 Bahamas Pediatric Vaccine Market Revenues & Volume, By Protein Subunit, 2022 - 2032F |
6.4 Bahamas Pediatric Vaccine Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Bahamas Pediatric Vaccine Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.4.3 Bahamas Pediatric Vaccine Market Revenues & Volume, By Pediatric Clinics, 2022 - 2032F |
6.4.4 Bahamas Pediatric Vaccine Market Revenues & Volume, By Research Institutes, 2022 - 2032F |
6.4.5 Bahamas Pediatric Vaccine Market Revenues & Volume, By Government Programs, 2022 - 2032F |
6.4.6 Bahamas Pediatric Vaccine Market Revenues & Volume, By Pharmacies, 2022 - 2032F |
6.5 Bahamas Pediatric Vaccine Market, By Age Group |
6.5.1 Overview and Analysis |
6.5.2 Bahamas Pediatric Vaccine Market Revenues & Volume, By Infants, 2022 - 2032F |
6.5.3 Bahamas Pediatric Vaccine Market Revenues & Volume, By Children, 2022 - 2032F |
6.5.4 Bahamas Pediatric Vaccine Market Revenues & Volume, By Adolescents, 2022 - 2032F |
6.5.5 Bahamas Pediatric Vaccine Market Revenues & Volume, By Neonates, 2022 - 2032F |
6.5.6 Bahamas Pediatric Vaccine Market Revenues & Volume, By Pre-Teens, 2022 - 2032F |
7 Bahamas Pediatric Vaccine Market Import-Export Trade Statistics |
7.1 Bahamas Pediatric Vaccine Market Export to Major Countries |
7.2 Bahamas Pediatric Vaccine Market Imports from Major Countries |
8 Bahamas Pediatric Vaccine Market Key Performance Indicators |
9 Bahamas Pediatric Vaccine Market - Opportunity Assessment |
9.1 Bahamas Pediatric Vaccine Market Opportunity Assessment, By Vaccine Type, 2022 & 2032F |
9.2 Bahamas Pediatric Vaccine Market Opportunity Assessment, By Disease Type, 2022 & 2032F |
9.3 Bahamas Pediatric Vaccine Market Opportunity Assessment, By Technology, 2022 & 2032F |
9.4 Bahamas Pediatric Vaccine Market Opportunity Assessment, By End User, 2022 & 2032F |
9.5 Bahamas Pediatric Vaccine Market Opportunity Assessment, By Age Group, 2022 & 2032F |
10 Bahamas Pediatric Vaccine Market - Competitive Landscape |
10.1 Bahamas Pediatric Vaccine Market Revenue Share, By Companies, 2025 |
10.2 Bahamas Pediatric Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here